JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer

Clinical trial NCT06751485 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06751485
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Cancer Primary Peritoneal Fallopian Tube Cancers

Start date: 2025-01-15
Primary completion: 2026-12-30
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.